Abstract
The anthrax toxin is composed of three proteins: protective antigen (PA), lethal factor (LF), and edema toxin (EF). The PA moiety carries EF and LF into the cytosol of mammalian cells via a mechanism that depends on the oligomerization of PA and transmembrane pore formation by the PA oligomer. Certain mutants of PA, termed dominant-negative (DN) mutants, can co-oligomerize with wild-type PA and disrupt the translocation ability of the pore. Here, we constructed a PA mutant library by introducing random mutations into domain II of PA and screened three new DN mutants of PA: V377E, T380S, and I432C. All the mutants inhibited the anthrax toxin action against sensitive cells. V377E had the strongest inhibitory effect and was further confirmed to be able to protect mice against a challenge with anthrax lethal toxin. Furthermore, we functionally characterized these mutants. The result showed that these mutations did not impair proteolytic activation or oligomer formation of PA, but impeded the prepore–pore conversion of the oligomer. These DN mutants of PA identified in our study may provide valuable information for elucidating the structure–function relationship of PA and for designing therapeutics for anthrax treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wang, J., & Roehrl, M. (2005). Medical Immunology, 4, 4.
Leppla, S. H. (1982). Proceedings of the National Academy of Sciences of the USA, 79, 3162–3166.
Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., et al. (1998). Science, 280, 734–737.
Ulmer, T. S., Soelaiman, S., Li, S., Klee, C. B., Tang, W. J., & Bax, A. (2003). The Journal of Biological Chemistry, 278, 29261–29266.
Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J., & Young, J. A. (2001). Nature, 414, 225–229.
Klimpel, K. R., Molloy, S. S., Thomas, G., & Leppla, S. H. (1992). Proceedings of the National Academy of Sciences of the USA, 89, 10277–10281.
Kintzer, A. F., Sterling, H. J., Tang, I. I., Williams, E. R., & Krantz, B. A. (2010). PLoS One, 5, e13888.
Kintzer, A. F., Thoren, K. L., Sterling, H. J., Dong, K. C., Feld, G. K., Tang, I. I., et al. (2009). Journal of Molecular Biology, 392, 614–629.
Mogridge, J., Cunningham, K., & Collier, R. J. (2002). Biochemistry, 41, 1079–1082.
Cunningham, K., Lacy, D. B., Mogridge, J., & Collier, R. J. (2002). Proceedings of the National Academy of Sciences of the USA, 99, 7049–7053.
Lacy, D. B., Mourez, M., Fouassier, A., & Collier, R. J. (2002). The Journal of Biological Chemistry, 277, 3006–3010.
Mogridge, J., Cunningham, K., Lacy, D. B., Mourez, M., & Collier, R. J. (2002). Proceedings of the National Academy of Sciences of the USA, 99, 7045–7048.
Abrami, L., Kunz, B., & van der Goot, F. G. (2010). Proceedings of the National Academy of Sciences of the USA, 107, 1420–1424.
Abrami, L., Liu, S., Cosson, P., Leppla, S., & Van Der Goot, F. (2003). Science Signaling, 160, 321.
Miller, C. J., Elliott, J. L., & Collier, R. J. (1999). Biochemistry, 38, 10432–10441.
Petosa, C., Collier, R. J., Klimpel, K. R., Leppla, S. H., & Liddington, R. C. (1997). Nature, 385, 833–838.
Gordon, V. M., Rehemtulla, A., & Leppla, S. H. (1997). Infection and Immunity, 65, 3370–3375.
Melnyk, R. A., & Collier, R. J. (2006). Proceedings of the National Academy of Sciences of the USA, 103, 9802–9807.
Mogridge, J., Mourez, M., & Collier, R. J. (2001). Journal of Bacteriology, 183, 2111–2116.
Rosovitz, M. J., Schuck, P., Varughese, M., Chopra, A. P., Mehra, V., Singh, Y., et al. (2003). The Journal of Biological Chemistry, 278, 30936–30944.
Sellman, B. R., Nassi, S., & Collier, R. J. (2001). The Journal of Biological Chemistry, 276, 8371–8376.
Rodriguez-Almazan, C., Zavala, L. E., Munoz-Garay, C., Jimenez-Juarez, N., Pacheco, S., Masson, L., et al. (2009). PLoS One, 4, e5545.
Vinion-Dubiel, A. D., McClain, M. S., Czajkowsky, D. M., Iwamoto, H., Ye, D., Cao, P., et al. (1999). The Journal of Biological Chemistry, 274, 37736–37742.
Sun, J., Lang, A. E., Aktories, K., & Collier, R. J. (2008). Proceedings of the National Academy of Sciences of the USA, 105, 4346–4351.
Janowiak, B. E., Fischer, A., & Collier, R. J. (2010). The Journal of Biological Chemistry, 285, 8130–8137.
Sellman, B. R., Mourez, M., & Collier, R. J. (2001). Science, 292, 695–697.
Singh, Y., Khanna, H., Chopra, A. P., & Mehra, V. (2001). The Journal of Biological Chemistry, 276, 22090–22094.
Wu, G., Feng, C., Hong, Y., Guo, A., Cao, S., Dong, J., et al. (2010). Applied Microbiology and Biotechnology, 87, 609–616.
Mourez, M., Yan, M., Lacy, D. B., Dillon, L., Bentsen, L., Marpoe, A., et al. (2003). Proceedings of the National Academy of Sciences of the USA, 100, 13803–13808.
Cao, S., Liu, Z., Guo, A., Li, Y., Zhang, C., Gaobing, W., et al. (2008). Protein Expression and Purification, 59, 25–30.
Yan, M., & Collier, R. J. (2003). Molecular Medicine, 9, 46–51.
Ahuja, N., Kumar, P., Alam, S., Gupta, M., & Bhatnagar, R. (2003). Biochemical and Biophysical Research Communications, 307, 446–450.
Lacy, D. B., Wigelsworth, D. J., Melnyk, R. A., Harrison, S. C., & Collier, R. J. (2004). Proceedings of the National Academy of Sciences of the USA, 101, 13147–13151.
Acknowledgments
This study was supported by a Key Project of the Chinese Ministry of Education (grant no. 306013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, G., Feng, C., Cao, S. et al. Identification of New Dominant-Negative Mutants of Anthrax Protective Antigen Using Directed Evolution. Appl Biochem Biotechnol 168, 1302–1310 (2012). https://doi.org/10.1007/s12010-012-9858-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-012-9858-6